Company intelligence / Profile preview
Celularity Inc.
Florham Park, New Jersey, USAorpha.net ↗
- Ownership
- Public · CELU
- Employees
- ~200
- Development stage
- Phase 1
01
Overview
Celularity has developed a diversified pipeline of off-the-shelf placental-derived allogeneic cell therapies and advanced regenerative biomaterial products. Its clinical-stage assets focus on cancer, degenerative disease, immune disorders, and wound healing. The company’s unique approach leverages the postpartum placenta as a source for both cellular therapeutics—including MLASCs, NK cells (unmodified/CAR), CAR-T—and commercialized wound care/biomaterial solutions. Several of its wound care/regenerative medicine products have received regulatory recognition or reimbursement coverage in the US.
- Therapeutic areas
- ImmunologyOtherOncologyNeurologyInfectious Diseases
- Modalities
- Allogeneic cell therapies (placental-derived)Genetically modified and unmodified natural killer (NK) cellsCAR T-cells (engineered T-cells)Mesenchymal-like adherent stromal cells (MLASCs)Advanced biomaterial products derived from placenta
- Industry
- Biotech
02
Drug pipeline
24 assets23 more assets in the full pipeline.
Request access →03
Partnerships
Exclusive territory agreement with CH Trading Group to distribute branded regenerative biomaterials in over 100 countries; other strategic collaborations with clinical-stage cell therapy companies.
04
Financials
- Market cap
- $44.6M
- Total revenue
- $4.1M
- Enterprise value
- $79.3M
Beyond the preview
Go deeper on Celularity Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celularity Inc..